XML 42 R33.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Fair Value Measurements - Estimated Fair Value of Significant Unobservable Inputs (Details) | Sep. 30, 2022
--- | ---
TomegaVax | Measurement Input Risk Free Interest Rate |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.041
TomegaVax | Measurement Input Expected Volatility |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.900
Humabs | Clinical and Regulatory Milestones | Probability of Achievement | Minimum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.221
Humabs | Clinical and Regulatory Milestones | Probability of Achievement | Maximum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.60
Humabs | Clinical and Regulatory Milestones | Probability of Achievement | Weighted Average |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | (0.421)
Humabs | Clinical and Regulatory Milestones | Measurement Input, Discount Rate | Minimum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.081
Humabs | Clinical and Regulatory Milestones | Measurement Input, Discount Rate | Maximum |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.092
Humabs | Clinical and Regulatory Milestones | Measurement Input, Discount Rate | Weighted Average |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | (0.087)
Humabs | Commercial Milestones | Probability of Achievement |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.260
Humabs | Commercial Milestones | Measurement Input Expected Revenue Volatility |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.900
Humabs | Commercial Milestones | Measurement Input, Discount Rate |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
Fair value contingent consideration measurement input | 0.120

X
- Definition Value of input used to measure contingent consideration liability from business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of input used to measure embedded derivative liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_EmbeddedDerivativeLiabilityMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=vir_TomegaVaxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=vir_MeasurementInputExpectedVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=vir_HumabsBiomedSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=vir_ClinicalAndRegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=vir_MeasurementInputProbabilityRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=vir_CommercialMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=vir_MeasurementInputExpectedRevenueVolatilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |